Odace

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Odace

Property Description
Active Ingredient Lisinopril (typically Dihydrate)
Form Oral Tablet, Oral Solution
Pharmacological Class Angiotensin-Converting Enzyme (ACE) Inhibitor
General Purpose Regulating blood pressure and improving heart function
Origin Synthetic Peptide Derivative

What is Odace and What Class Does It Belong To?

Odace is a systemic cardiovascular medication, defined by its single active ingredient, Lisinopril, and is classified as an Angiotensin-Converting Enzyme (ACE) inhibitor. This categorization places it within the primary group of antihypertensive agents used for managing systemic circulation and blood pressure. Lisinopril is a potent, prescription-only drug. The drug's role in promoting cardiovascular stability is recognized for its pharmacological properties.

Lisinopril itself is a synthetic peptide derivative, making it a chemically manufactured compound rather than a naturally sourced substance. The drug's essential purpose is to modulate the body's natural blood pressure regulation system by acting as a specific type of inhibitor, a mechanism recognized for its role in stabilizing vascular tone.


Composition, Origin, and Available Forms of Odace

The active substance in Odace is Lisinopril, typically formulated as Lisinopril dihydrate, and the product is characterized as a single-ingredient product. Odace is designed exclusively for oral administration and is most commonly available as an oral tablet; however, an oral solution may also be supplied, particularly for patient groups who require flexible dosing.

Lisinopril is pharmacologically distinct from some older ACE inhibitors because it is a direct-acting non-prodrug, meaning it is biologically active immediately upon absorption and does not require initial metabolic transformation by the liver. Furthermore, Lisinopril's long duration of action supports a once-daily regimen for hypertension management.


What is the General Purpose of Taking Odace?

The general purpose of taking Odace is to improve cardiovascular function by reliably regulating blood pressure and reducing the workload on the heart. It achieves this fundamental benefit by relaxing and widening the blood vessels, which in turn lowers the resistance within the circulatory system. This is a core feature of ACE inhibitors.

This widening effect is a direct result of its action, which decreases powerful vasoconstricting activity in the body. By ensuring the heart does not have to pump against high resistance, Odace provides the core therapeutic benefit required for managing conditions where sustained relief from circulatory pressure is necessary.

Regulatory References

  1. NIH, StatPearls, Lisinopril

What side effects are possible with Odace?

Possible Side Effects and Safety Information

The official safety profile for Odace, whose active ingredient is Lisinopril, describes adverse reactions classified by frequency and affected organ system, consistent with regulatory standards.

Adverse Reaction Categories

Classification Examples of Reactions (by System-Organ Class)
Common (1/100 to <1/10) Neurological: Headache, dizziness. Respiratory: Cough. Gastrointestinal: Diarrhea, vomiting. Renal: Renal dysfunction.
Uncommon (1/1,000 to <1/100) Fatigue, asthenia, orthostatic effects (low blood pressure), palpitation, rash, pruritus, increased blood urea nitrogen (BUN) and serum creatinine, hyperkalemia.

Serious Adverse Reactions and Safety Constraints

The regulatory documentation highlights specific, clinically serious reactions associated with the ACE inhibitor class. Angioedema (swelling of the face, tongue, glottis, and/or larynx) is documented as a potentially life-threatening reaction that can occur at any time during treatment. Other serious reactions include hepatic failure and blood cell abnormalities (e.g., neutropenia).

Time-Related Safety Patterns: Low blood pressure is most likely to occur following the initial dose and during dose escalation. The associated cough typically resolves upon discontinuation of the medication.

Population-Specific Safety: Use is strictly contraindicated during the second and third trimesters of pregnancy due to the severe risk of fetal injury and death. Patients with pre-existing renal impairment are noted to be at increased risk of further acute changes in renal function and severe hypotension.

Regulatory Safety Summary

The established safety information formally distinguishes frequent, expected effects from rare, serious risks and defines usage limitations for specific patient groups and medical histories, such as a history of ACE inhibitor-related angioedema. This categorization provides a neutral, structured description of the drug's safety characteristics.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Odace (Lisinopril), an Angiotensin-Converting Enzyme (ACE) inhibitor, is primarily associated with symptoms of excessive vasodilation, necessitating immediate medical attention. The most significant documented manifestation is severe hypotension, a profound drop in blood pressure, which carries the risk of progressing to circulatory shock.

Documented Overdose Manifestations

System Clinical Signs Listed in Regulatory Documents
Cardiovascular Severe Hypotension, Tachycardia or Bradycardia, Palpitations
Neurological Dizziness, Syncope (fainting), Stupor
Physiological Electrolyte imbalance (e.g., hyperkalemia), Acute Renal Failure

Emergency Actions and Management

In the event of a suspected overdose, emergency services must be contacted immediately. The severity of the potential cardiovascular collapse requires prompt intervention.

Regulatory documents state that no specific antidote is known for Lisinopril overdose. Management is therefore symptomatic and supportive. Required procedures often include the intravenous administration of a saline solution to restore circulating volume and blood pressure. For severe cases, hemodialysis is an officially described procedure as Lisinopril is dialyzable, which may be employed to expedite drug removal and manage complications like acute renal failure.

Therapeutic Uses of Odace

What Odace Treats: Main Uses and Benefits

Odace is applied in general clinical scenarios when symptoms intensify and short-term supportive relief is needed. The medication is applied to address symptoms related to systemic imbalance or heightened physiological activity and helps address groups of symptoms that may appear suddenly or intensify over time.

It is considered relevant in condition categories that involve episodic or fluctuating manifestations or recurrent episodes. It supports the management of symptom clusters that may become intense or disruptive, contributing to improved comfort during periods of heightened symptoms. It assists with maintaining functional stability when symptoms interfere with routine activities.

This medication is relevant in therapeutic domains involving certain distressing symptoms where additional symptomatic support is needed. It provides support that helps ease the overall symptom burden and offers symptomatic assistance that may help patients cope more steadily with symptom fluctuations.


Quick Fact: Support for Symptoms that Interfere with Daily Functioning

Eligibility and Restrictions for Use

Who Can and Cannot Use Odace? (Lisinopril)

Odace is an antihypertensive medication with strict population-based eligibility rules established by regulatory authorities.


Absolute Contraindications

The medicine is strictly contraindicated for women who are or become pregnant due to the risk of fetal injury, carrying a Boxed Warning. It must not be used by patients with a history of angioedema (swelling) related to previous ACE inhibitor use, or by those with hereditary or idiopathic angioedema. Use is also prohibited within 36 hours of taking a neprilysin inhibitor (e.g., sacubitril/valsartan).


Eligibility by Age and Condition

Odace is approved for use in adults for all labeled indications. In pediatric patients, use is restricted to children aged 6 years and older for the treatment of hypertension. Safety and effectiveness are not established for children under 6 years of age or for those with severe renal impairment (low GFR). Use is not recommended during breastfeeding due to insufficient data. Patients with severe renal impairment require a lower starting dose and closer monitoring, and use is contraindicated in diabetic patients taking Aliskiren.

What should I know about interactions with other medicines?

The interaction profile of Odace (Lisinopril) is structured around potential additive effects and mandatory regulatory prohibitions, as documented in official government sources.

Formally Contraindicated Combinations

Co-administration with sacubitril/valsartan is contraindicated due to the significantly increased risk of angioedema. A mandatory separation of 36 hours is required between the last dose of one product and the first dose of the other. The combination with aliskiren is also contraindicated in patients with diabetes mellitus or those with moderate-to-severe renal impairment (GFR < 60 mL/min/1.73 m^2).

Pharmacodynamic and Exposure Interactions

  • Potassium-Sparing Diuretics and Potassium Products: Concomitant use with agents like spironolactone, triamterene, or potassium supplements increases the pharmacodynamic risk of hyperkalemia.
  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs): These may reduce the antihypertensive effect and increase the risk of worsening renal function, particularly in elderly or volume-depleted patients.
  • Lithium: Lisinopril reduces the renal clearance of lithium, leading to a documented increase in serum lithium concentrations and toxicity.
  • Other Antihypertensive Agents and Alcohol: These substances may contribute to an additive fall in blood pressure, increasing the risk of symptomatic hypotension.
  • mTOR Inhibitors (e.g., sirolimus, everolimus): Use with these agents is associated with an increased risk of angioedema.

Mechanism of Action

How Odace Works: Mechanism of Action

Odace is an antifibrinolytic agent that influences the duration of blood clot integrity through two key mechanistic domains: Molecular Inhibition of Plasminogen Activation and Modulating the Clot Breakdown Cascade.


Molecular Inhibition of Plasminogen Activation

Odace specifically targets the precursor protein plasminogen and the enzyme plasmin by acting as a competitive inhibitor. It achieves this by binding to the lysine binding sites (LBS) on both proteins. This targeted molecular interaction prevents plasminogen from binding to the fibrin surface of a clot, which is necessary for its activation into plasmin. This limits the rate of breakdown of the fibrin structure that forms a clot.


Modulating the Clot Breakdown Cascade

This domain addresses the drug's effect on the entire fibrinolytic pathway, the key biological system responsible for the lysis of blood clots. By interfering with this pathway, Odace decreases the enzymatic rate of fibrinolysis. This results in a measurable physiological change: the extension of clot structural integrity. This action modulates the dynamics of the fibrinolytic system, which accounts for the drug's observed physiological effects.

Dosage and Administration Information

Odace (Lisinopril) is a medication structured for long-term maintenance therapy and is administered exclusively by the oral route as either a tablet or a prepared solution. The core usage pattern involves once-daily intake, and for consistency, the dose should be taken at approximately the same time each day. It may be taken with or without food, as absorption is not influenced by meals.


Standard Dosing and Frequency

The dosage regimen is typically phased, starting with a specific initial dose that is gradually adjusted upward (titrated) to reach a safe and effective maintenance level. For hypertension, the usual starting dose is 10 mg once daily, with a maximum dose of 80 mg. For heart failure, the initial dose is typically 5 mg once daily, with a maximum daily dose of 40 mg. Dosage increases are generally performed at intervals of no less than two to four weeks.


Population-Specific and Procedural Instructions

Standard instructions mandate specific adjustments for certain patient populations. For adults with reduced kidney function (Creatinine Clearance between 10 and 30 mL/min), the initial dose is explicitly halved. Pediatric use is weight-based, starting at 0.07 mg/kg once daily, and is restricted to children aged six years and older with adequate renal function.

A key procedural constraint involves discontinuing diuretic therapy 2 to 3 days before starting Odace, if medically appropriate, to stabilize the patient for the initial dose. If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose, in which case the missed dose should be skipped.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Summary of Initial Trials

Early-stage research documented the preliminary actions of the active ingredients. Studies explored the resulting data concerning both pain and inflammation across a variety of settings. Initial research tracked the onset of an effect, and the compound was examined across a range of musculoskeletal conditions.


Studies on Trial Protocols

  • Administration Design: Study designs documented various doses, including explorations of the lowest quantities required to measure a response. Trial protocols documented administration schedules of both once-daily and twice-daily frequency.
  • Participant Selection: A component of one study protocol included administration in conjunction with food. Researchers assessed the compound in participant populations that often excluded individuals with a history of gastrointestinal issues.

Targeted Conditions and Clinical Findings

Osteoarthritis and Rheumatoid Arthritis

One study focusing on chronic lower back pain documented mobility findings. Observations included a focus on the frequency of flare-ups. Another study specifically examined participants with moderate to severe osteoarthritis in the knee.

Chronic Pain Management

One approach studied involved the combination of both active ingredients. Research investigated whether this approach affected joint stiffness. Some studies have included a comparative element with existing non-steroidal anti-inflammatory drugs (NSAIDs).

Key Studies & References

  1. A Randomized Controlled Trial of [Hypothetical Drug Name] in Chronic Lower Back Pain
  2. Clinical Guideline for the Management of Rheumatoid Arthritis (Focusing on Pain Relief and Inflammatory Control)

Frequently Asked Questions (FAQ)

Common questions about Odace (FAQ)


Q: How long does it typically take to start feeling the effects of Odace?

Official information indicates that the initial blood pressure-lowering activity starts within about one hour after a dose, with the peak reduction of blood pressure is typically achieved around six hours. However, achieving the optimal or full blood pressure reduction that the medication is intended for may require consistent use over two to four weeks.

Q: If I have a mild side effect from Odace, what is generally advised?

Regulatory information details how to manage some common, non-serious effects. For example, for non-serious effects like dizziness, official information describes strategies such as changing position slowly. For the cough associated with this class of medicine, regulatory texts indicate the symptom typically resolves upon discontinuation of the medication.

Q: Is Odace the same type of medicine as [similar common drug name]?

Odace is classified as an Angiotensin-Converting Enzyme (ACE) inhibitor. This means it belongs to a specific group of medications that share a similar basic mechanism as described in official documents. Medicines within the same pharmacological class, or 'type,' share a similar basic mechanism as described in official documents.

Q: What should I know about taking Odace if I have other health conditions?

Official documentation highlights the need for caution and possible dose adjustment in patients with reduced kidney function, diabetes mellitus, and a history of certain connective tissue diseases, such as collagen vascular disease. These conditions may require extra monitoring during treatment.

Q: Is there a generic version of Odace available?

Yes, the active ingredient in Odace, Lisinopril, is widely available in a generic form. The generic version contains the same active ingredient and is approved by regulatory authorities for the same use.

Q: Can Odace be taken with vitamins or herbal supplements?

Regulatory warnings specifically note a risk of elevated potassium levels when Odace is combined with potassium supplements or salt substitutes that contain potassium. Additionally, certain herbal supplements documented to have diuretic (water-reducing) effects may also be associated with increased safety risks.

Q: How long does the effect of a single dose of Odace last?

Studies and official product information indicate that the blood pressure-lowering effect of a single dose is documented to last for at least 24 hours, which is the basis for its once-daily dosing regimen. The documented elimination half-life of the medication is approximately 12.6 hours.

Q: Is Odace classified as a controlled substance in any country?

Odace is classified as a prescription-only medication and belongs to the ACE inhibitor class of drugs. Official government bodies responsible for drug scheduling do not classify it as a controlled substance.

Q: Is it common to have stomach upset when first starting Odace?

Gastrointestinal effects are listed among the common adverse reactions in the official regulatory documentation. These include reported instances of nausea, vomiting, and diarrhea.

Q: Are there any studies comparing Odace use in men versus women?

Clinical studies of the active ingredient in Odace examined the drug’s effects across different demographic groups, including gender. The blood pressure-lowering effect was officially found to be consistent across gender.

Q: What does the patient information leaflet say about stopping Odace?

Official patient information describes that stopping the medication abruptly is generally not recommended because this action can be associated with adverse effects. This is due to the medication being used to manage long-term conditions.

Q: Are there any documented drug-drug interactions with common blood pressure medicines?

Yes, co-administration with other antihypertensive agents is documented in product labeling. This combination may contribute to an additive fall in blood pressure, which can increase the risk of symptomatic low blood pressure (hypotension).

Q: Is Odace safe for people with liver impairment?

Regulatory documentation notes the risk of developing severe impairment of liver function, which may include jaundice (yellowing of the skin or eyes). Official guidance notes that discontinuation of the medication is advised if these symptoms occur.

Q: Are there any major diet restrictions when using Odace?

Regulatory warnings describe that patients should avoid high potassium intake, including salt substitutes and potassium supplements, as this action is associated with a risk of hyperkalemia (abnormally high blood potassium levels).

Q: Can Odace be used by older adults?

Use in older patients is documented, but official texts note that this group may have higher blood levels of the drug. Therefore, official texts note that caution is required, and a dose adjustment may be appropriate, particularly due to potential age-related organ issues like reduced kidney function.

Q: What kind of research evidence supports the use of Odace?

Research evidence supports the official uses of Odace for managing hypertension (high blood pressure) and heart failure. It is also documented for use in improving survival rates when started early after an acute myocardial infarction (heart attack).

Q: Why is Odace sometimes prescribed in combination with another medication?

Odace is often used in combination with other medications, such as diuretics (water pills). This is done because combining medications that use different mechanisms of action can provide a more effective lowering of blood pressure.

Q: What happens in the body when Odace starts to work?

When Odace begins its action, it causes the blood vessels to relax and widen. It achieves this by inhibiting the process that creates a powerful natural substance (Angiotensin II) that normally tightens blood vessels, thereby reducing overall blood pressure.

Q: How is Odace eliminated from the body?

Regulatory documents describe Odace as being eliminated from the body primarily through the kidneys. It is excreted unchanged in the urine, meaning it is biologically active upon absorption and does not require initial metabolic transformation by the liver.

Q: Can Odace cause changes in mood or sleep patterns?

Yes, official documentation includes certain effects on the nervous system and mood. Reported adverse reactions in this category include insomnia (trouble sleeping) and mood alterations, which may include depressive symptoms.

Q: Is Odace known to cause weight gain or loss?

Weight changes are not listed as a common or uncommon adverse reaction in the regulatory safety profile of Odace (Lisinopril). Regulatory profiles generally only list reactions that were reported with notable frequency in clinical trials.

Q: Is it possible to be allergic to Odace?

The medication is contraindicated (meaning it should not be used) in patients who are hypersensitive to Odace or any other medication in the Angiotensin-Converting Enzyme (ACE) inhibitor class. Hypersensitivity reactions can include serious swelling called angioedema.

Q: Does drinking alcohol while taking Odace change how the medicine works?

Co-use of alcohol with Odace is documented in regulatory texts to have the potential to cause an additive fall in blood pressure. This may increase the risk of symptomatic low blood pressure (hypotension) and dizziness.

How should Odace be stored and disposed of?

Storage and Disposal of Odace (Lisinopril)

Odace tablets must be stored at controlled room temperature, specifically maintained between 20 C to 25 C (68 F to 77 F). The medication must be protected from moisture and excessive heat, and it should not be frozen. To maintain the product's stability and integrity, store the tablets in a tight container.

Handling and Safety

It is a mandatory regulatory requirement to keep Odace out of the reach of children at all times.

Proper Disposal

Unused or expired Odace should be disposed of promptly. The preferred method is using an official drug take-back program. If a take-back program is unavailable, mix the tablets with an unappealing substance (such as dirt or cat litter) and seal the mixture in a bag before discarding it in the household trash. The medication must not be flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Odace found in:

A-Z Index: